# Medicare Multi-Cancer Early Detection Screening Coverage Act

This bill would require Medicare to cover a new type of cancer screening test that can detect multiple cancers at once from a single blood sample. Right now, Medicare covers specific cancer screenings like mammograms for breast cancer and colonoscopies for colon cancer, but these tests look for one type of cancer at a time. This bill would add coverage for multi-cancer early detection tests—sometimes called "liquid biopsies"—which use advanced blood work to search for signs of several different cancers simultaneously, such as pancreatic, ovarian, liver, and lung cancers.

The practical effect is that Medicare beneficiaries (people 65 and older, plus some younger people with disabilities) would be able to get these newer screening tests covered by their insurance without having to pay out of pocket. This could make it easier for seniors to catch certain cancers earlier, when they're often more treatable. However, the bill doesn't specify exactly which multi-cancer tests would qualify or how often people could get them, leaving those details to be worked out by Medicare officials later. This is important because these tests are still relatively new, and there's ongoing debate in the medical community about how well they actually work and whether they should be used as routine screening for everyone or only for people at higher risk.

The bill essentially opens the door for Medicare to start paying for these tests, which could increase access for older Americans but might also increase healthcare costs since these tests can be expensive. Insurance companies and healthcare providers would need to figure out the specifics of coverage, such as eligibility requirements and frequency of testing.

Medicare Multi-Cancer Early Detection Screening Coverage Act

Crapo, Mike

Medicare Multi-Cancer Early Detection Screening Coverage Act This bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare &amp; Medicaid Services determines such coverage is appropriate.